MGMT and glioblastoma: Previous studies reported that age, MGMT promoter and IDH1 mutation were one of the main prognostic factors for GBM [45], so we compared the predictive ability of age, MGMT promoter and IDH1 mutation with that of the PCG-lncRNA signature, and the ROC analysis results confirmed the signature had a superior survival predictive power.